Amicus Therapeutics Inc’s recently made public that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $87496.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Amicus Therapeutics Inc’s recently made public that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $87496.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Amicus Therapeutics Inc revealed its President and CEO Campbell Bradley L unloaded Company’s shares for reported $87496.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics
Amicus Therapeutics Inc’s recently made public that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $87496.0